Alzheimer’s disease and the β-amyloid peptide : Aβ conformers and mechanisms of spreading
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Proc Natl Acad Sci USA 2017b; 114: 13018-13023. (doi:10.1073/pnas.1713215114)
Tübingen, Universität Tübingen, Dissertation, 2020
- Keyword
-
Amyloid
Alzheimerkrankheit
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2022
- Creator
- Contributor
-
Jucker, Mathias
- URN
-
urn:nbn:de:bsz:21-dspace-1008502
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beschorner, Natalie
- Jucker, Mathias
- Universitätsbibliothek Tübingen
Time of origin
- 2022
Other Objects (12)
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis